5-148120053-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_006846.4(SPINK5):​c.2358C>T​(p.Leu786Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.6 in 1,612,812 control chromosomes in the GnomAD database, including 295,898 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.54 ( 23521 hom., cov: 32)
Exomes 𝑓: 0.61 ( 272377 hom. )

Consequence

SPINK5
NM_006846.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7O:1

Conservation

PhyloP100: -2.75

Publications

22 publications found
Variant links:
Genes affected
SPINK5 (HGNC:15464): (serine peptidase inhibitor Kazal type 5) This gene encodes a multidomain serine protease inhibitor that contains 15 potential inhibitory domains. The encoded preproprotein is proteolytically processed to generate multiple protein products, which may exhibit unique activities and specificities. These proteins may play a role in skin and hair morphogenesis, as well as anti-inflammatory and antimicrobial protection of mucous epithelia. Mutations in this gene may result in Netherton syndrome, a disorder characterized by ichthyosis, defective cornification, and atopy. This gene is present in a gene cluster on chromosome 5. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015]
FBXO38-DT (HGNC:55589): (FBXO38 divergent transcript)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.68).
BP6
Variant 5-148120053-C-T is Benign according to our data. Variant chr5-148120053-C-T is described in ClinVar as Benign. ClinVar VariationId is 260050.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.75 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.63 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SPINK5NM_006846.4 linkc.2358C>T p.Leu786Leu synonymous_variant Exon 25 of 33 ENST00000256084.8 NP_006837.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SPINK5ENST00000256084.8 linkc.2358C>T p.Leu786Leu synonymous_variant Exon 25 of 33 1 NM_006846.4 ENSP00000256084.7

Frequencies

GnomAD3 genomes
AF:
0.542
AC:
82404
AN:
151940
Hom.:
23498
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.353
Gnomad AMI
AF:
0.594
Gnomad AMR
AF:
0.640
Gnomad ASJ
AF:
0.540
Gnomad EAS
AF:
0.471
Gnomad SAS
AF:
0.504
Gnomad FIN
AF:
0.632
Gnomad MID
AF:
0.535
Gnomad NFE
AF:
0.629
Gnomad OTH
AF:
0.545
GnomAD2 exomes
AF:
0.593
AC:
147752
AN:
248974
AF XY:
0.589
show subpopulations
Gnomad AFR exome
AF:
0.349
Gnomad AMR exome
AF:
0.742
Gnomad ASJ exome
AF:
0.550
Gnomad EAS exome
AF:
0.460
Gnomad FIN exome
AF:
0.641
Gnomad NFE exome
AF:
0.621
Gnomad OTH exome
AF:
0.595
GnomAD4 exome
AF:
0.607
AC:
885957
AN:
1460754
Hom.:
272377
Cov.:
44
AF XY:
0.604
AC XY:
438680
AN XY:
726760
show subpopulations
African (AFR)
AF:
0.345
AC:
11555
AN:
33460
American (AMR)
AF:
0.726
AC:
32478
AN:
44708
Ashkenazi Jewish (ASJ)
AF:
0.550
AC:
14364
AN:
26122
East Asian (EAS)
AF:
0.437
AC:
17350
AN:
39684
South Asian (SAS)
AF:
0.509
AC:
43905
AN:
86224
European-Finnish (FIN)
AF:
0.642
AC:
34268
AN:
53398
Middle Eastern (MID)
AF:
0.534
AC:
3077
AN:
5766
European-Non Finnish (NFE)
AF:
0.624
AC:
693658
AN:
1111034
Other (OTH)
AF:
0.585
AC:
35302
AN:
60358
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.456
Heterozygous variant carriers
0
18309
36618
54927
73236
91545
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18404
36808
55212
73616
92020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.542
AC:
82467
AN:
152058
Hom.:
23521
Cov.:
32
AF XY:
0.542
AC XY:
40292
AN XY:
74314
show subpopulations
African (AFR)
AF:
0.353
AC:
14635
AN:
41452
American (AMR)
AF:
0.640
AC:
9790
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.540
AC:
1874
AN:
3472
East Asian (EAS)
AF:
0.470
AC:
2431
AN:
5168
South Asian (SAS)
AF:
0.506
AC:
2437
AN:
4820
European-Finnish (FIN)
AF:
0.632
AC:
6677
AN:
10566
Middle Eastern (MID)
AF:
0.517
AC:
152
AN:
294
European-Non Finnish (NFE)
AF:
0.629
AC:
42780
AN:
67978
Other (OTH)
AF:
0.546
AC:
1153
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1876
3751
5627
7502
9378
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
714
1428
2142
2856
3570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.598
Hom.:
25063
Bravo
AF:
0.536
Asia WGS
AF:
0.528
AC:
1832
AN:
3478
EpiCase
AF:
0.617
EpiControl
AF:
0.616

ClinVar

Significance: Benign
Submissions summary: Benign:7Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Jan 24, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 91% of patients studied by a panel of primary immunodeficiencies. Number of patients: 80. Only high quality variants are reported. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

Netherton syndrome Benign:2
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1Other:1
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
GenomeConnect, ClinGen
Significance:not provided
Review Status:no classification provided
Collection Method:phenotyping only

Variant interpreted as Benign and reported on 04-27-2020 by Lab or GTR ID 500031. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. This variant was reported in an individual referred for clinical diagnostic genetic testing. -

Ichthyosis linearis circumflexa Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.68
CADD
Benign
2.5
DANN
Benign
0.66
PhyloP100
-2.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17704908; hg19: chr5-147499616; COSMIC: COSV56249020; COSMIC: COSV56249020; API